FIELD: medicine. SUBSTANCE: invention relates to agents used for treatment of patients with freezings. Invention proposes xymedone that is N-(β-hydroxyethyl)-4,6-dimethyldihydropyrimidione-2. Use of xymedone in clinic results to improvement of microcirculation, acceleration of processes of reparative regeneration in patients with freezings. EFFECT: enhanced effectiveness of preparation, decreased treatment and hospitalization period. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING THE CASES OF NEUROTROPHIC NECROTIC TISSULAR DEFECTS | 2000 |
|
RU2197290C2 |
HEPATOPROTECTIVE AND DETOXICATING AGENT FOR TREATMENT AND PROPHYLAXIS OF COMPLICATIONS OF SUPPURATIVE-SEPTIC DISEASES | 2001 |
|
RU2195283C1 |
PREPARATION WITH SELECTIVE EFFECT AND METHOD FOR TREATMENT OF OSTEOARTHROSIS | 2001 |
|
RU2211037C1 |
PREPARATION FOR TREATMENT OF SLUGGISH WOUND AND TROPHIC ULCER (VARIANTS) | 1998 |
|
RU2148989C1 |
METHOD FOR TREATING PURULENT-INFLAMMATORY DISEASES OF SKIN AND SUBCUTANEOUS FIBER | 2001 |
|
RU2217065C2 |
ADHESIVE CURATIVE-PROPHYLACTIC COMPOSITION | 2001 |
|
RU2188016C1 |
METHOD FOR TREATING GASTROENTERIC TRACT WOUNDS | 1997 |
|
RU2159616C2 |
METHOD FOR TREATMENT OF PATIENTS SUFFERING FROM CHRONIC OSTEOMYELITIS | 1992 |
|
RU2073514C1 |
METHOD FOR PURULENT-INFLAMMATORY DISEASES OF PARANASAL SINUSES | 2004 |
|
RU2268048C1 |
METHOD OF TREATMENT OF AUTOIMMUNE GENERAL DISEASES AND MEDICAL PRODUCT | 2007 |
|
RU2361588C2 |
Authors
Dates
2000-10-10—Published
1997-07-10—Filed